AHFS Drug Information (AHFS DI) is a leading source of evidence-based drug information.

AHFS DI is a dependable, comprehensive and objective database for FDA approved drug products. Inclusion of evidence-based data on labelled and unlabelled drug use makes this a valuable reference for healthcare professionals seeking to provide their patients with safe and effective therapy.

AHFS DI is published by the American Society of Health-System Pharmacists (ASHP).

SubscribeContent Updates
Features and Benefits icon

Comprehensive: Highly detailed monographs with extensive information on the chemistry and clinical application of all FDA approved drugs

Features and Benefits icon

Evidence-based: Built on evidence from primary sources and peer reviewed by over 500 pharmacists, physicians and healthcare professionals

Features and Benefits icon

Dependable: Fast and easy access to content that is revalidated, revised and updated regularly as new information arrives

Features and Benefits icon

Objective: The information is compiled without any influence from manufacturers, insurers, regulators or other interested parties

Publication Updates

11 Jan
AHFS Drug Information logo
AHFS Drug Information January 2022 Update

This update contains 2 new monographs and 43 revised monographs.

New monographs: Asciminib; Tick-borne Encephalitis Vaccine

Revised monographs: Linezolid; Fondaparinux; Flurbiprofen; Bedaquiline; Olaparib; Obeticholic Acid; Rucaparib; Niraparib; Pretomanid; Lefamulin; Tazemetostat; Cefiderocol; Capmatinib; Ofatumumab; COVID-19 Vaccine (Pfizer-BioNTech); Relugolix; Fenoprofen; Indomethacin; Mefenamic Acid; Tolmetin; Sulindac; Prochlorperazine; Trifluoperazine; Perphenazine; fluPHENAZine; Neostigmine; Molindone; Meclofenamate; Loxapine; Chloroquine; Hydroxychloroquine; Thiothixene; Aspirin; Salsalate; Phenothiazines General Statement; Diflunisal; Piroxicam; Ketoprofen; Pimozide; cloZAPine; Etodolac; Nabumetone; Oxaprozin

07 Dec
AHFS Drug Information logo
AHFS December 2021 Update

This update contains 5 new monographs and 18 revised monographs.

New monographs: Clascoterone; Tisotumab Vedotin-tftv; Maralixibat; Atogepant; Avacopan

Revised monographs: Meloxicam; Influenza Vaccine Live Intranasal; Tocilizumab; Influenza Vaccine Recombinant; Atezolizumab; Brexpiprazole; Cariprazine; COVID-19 Vaccine (Pfizer-BioNTech); COVID-19 Vaccine (Moderna); COVID-19 Vaccine (Janssen); Naproxen; HYDROmorphone; Ibuprofen; Levodopa/Carbidopa; Diclofenac; Ketorolac; Influenza Virus Vaccine Inactivated; Celecoxib

09 Nov
AHFS Drug Information logo
AHFS November 2021 Update

This update contains 3 new monographs, 26 revised monographs and 3 new MedWatch alerts.

New monographs: Difelikefalin Acetate; Mobocertinib Succinate; Ruxolitinib Phosphate

Revised monographs: Influenza Vaccine Live Intranasal; Omega-3-acid Ethyl Esters; Prasugrel; Ticagrelor; Pertuzumab; Icosapent Ethyl; Influenza Vaccine Recombinant; Tofacitinib; Peramivir; Edoxaban Tosylate; Venetoclax; Baricitinib; Baloxavir; Upadacitinib; Istradefylline; Tucatinib; COVID-19 Vaccine (Pfizer-BioNTech); COVID-19 Vaccine (Moderna); Bamlanivimab and Etesevimab; fentaNYL; Enoxaparin; lamoTRIgine; Influenza Virus Vaccine Inactivated; Antiretroviral Agents General Statement; Zanamivir; Oseltamivir

New MedWatch alerts on the following monographs: Tofacitinib; Baricitinib, Upadacitinib

12 Oct
AHFS Drug Information logo
AHFS October 2021 Update

This update contains 6 new monographs, 27 revised monographs, and 3 discontinued monographs.

New monographs: Odevixibat; Belumosudil; Fexinidazole; Anifrolumab; Avalglucosidase Alfa; Belzutifan

Revised monographs: Bendamustine; Tofacitinib; Trabectedin; Trifluridine and Tipiracil; Mepolizumab; Opicapone; Casirivimab and Imdevimab; COVID-19 Vaccine (Pfizer-BioNTech); COVID-19 Vaccine (Moderna); Bamlanivimab and Etesevimab; Fluorides; Dexamethasone; Hydrocortisone; methylPREDNISolone; predniSONE; Antituberculosis Agents General Statement; Corticosteroids General Statement; Erythromycins General Statement; Amoxicillin/Clavulanate; Aminopenicillins General Statement; Natural Penicillins General Statement; Penicillinase-Resistant Penicillins General Statement; Buprenorphine; Ritonavir; Antiretroviral Agents General Statement; Rifapentine; Efavirenz

Discontinued monographs: Capreomycin; Didanosine; Stavudine

14 Sep
AHFS Drug Information logo
AHFS September 2021 Update

This update contains 4 new monographs, 31 revised monographs, 2 discontinued monographs and 9 new MedWatch alerts.

New monographs: Ibrexafungerp; Bupivacaine and Meloxicam; Asparaginase (Erwinia chrysanthemi) (recombinant)-rywn; Finerenone

Revised monographs: Atorvastatin; HMG-CoA Reductase Inhibitors General Statement; Alemtuzumab; Fenofibrate; Colesevelam; Rosuvastatin; Pitavastatin; Alirocumab; Evolocumab; Cannabidiol; Isatuximab-irfc; Sacituzumab Govitecan-hziy; Tucatinib; Capmatinib; Ofatumumab; Casirivimab and Imdevimab; Oliceridine Fumarate; Fluorouracil; Colestipol; Melphalan; Bacitracin; Niacin; Cholestyramine; Opiate Agonists General Statement; Naltrexone; Gemfibrozil; Lovastatin; CloZAPine; Pravastatin; Simvastatin; Fluvastatin

Discontinued monographs: Betrixaban; Bacitracin

New MedWatch alerts on the following monographs: HMG-CoA Reductase Inhibitors General Statement; Atorvastatin; Rosuvastatin; Pitavastatin; Lovastatin; Pravastatin; Simvastatin; Fluvastatin; Melphalan

10 Aug
AHFS Drug Information logo
AHFS August 2021 Update

This update contains 6 new monographs, 33 revised monographs, 1 discontinued monograph and 1 new MedWatch alert.

New monographs: Sotorasib; Infigratinib; Relugolix, Estradiol, and Norethindrone Acetate; Aducanumab-avwa; Plasminogen, Human-tmvh; Pegcetacoplan

Revised monographs: Repaglinide; Nateglinide; Exenatide; SITagliptin; Miglitol; Liraglutide; SAXagliptin; Linagliptin; Alogliptin; Canagliflozin; Dapagliflozin Propanediol; Dulaglutide; Empagliflozin; Obeticholic Acid; Lixisenatide; Semaglutide; Ertugliflozin L-pyroglutamic Acid; COVID-19 Vaccine (Pfizer-BioNTech); COVID-19 Vaccine (Moderna); Bamlanivimab and Etesevimab; TOLBUTamide; GlyBURIDE; GlipiZIDE; BusPIRone; Rifabutin; MetFORMIN; Acarbose; Glimepiride; Meropenem; Pioglitazone; Rosiglitazone; EpiRUBicin; Exemestane

Discontinued monograph: Bamlanivimab

New MedWatch alerts on the following monograph: Obeticholic Acid

View more View all content updates